1) 5%～7% sodium hydrogen carbonate
5%～7%碳酸酸氢钠
2) sodium bicarbonate
碳酸氢钠
1.
Manufacture of Sodium Bicarbonate Tablets by wet mixing granulation;
湿法混合制粒法制备碳酸氢钠片
2.
Preliminary study on desulfurization by sodium bicarbonate and discussion of its optimum condition;
碳酸氢钠脱硫及其优化条件的筛选探讨
3.
Evaluation of the administration of sodium bicarbonate during cardiopulmonary resuscitation;
碳酸氢钠在心肺复苏中的应用
3) NaHCO_3
碳酸氢钠
1.
The Influences of NaHCO_3 Added in Diets in Summer on Layer Performance and Biochemical data;
碳酸氢钠对夏季蛋鸡生产性能及生化指标影响的研究
2.
The Synthesis of Azole Organic Compounds and Study on Corrosion Inhibition for Copper in NaHCO_3 Medium;
唑类有机化合物的合成及其在碳酸氢钠介质中对铜缓蚀性能的研究
3.
There was no significant difference between NaF group and NaHCO_3 group(P>0.
目的研究碳酸氢钠溶液对人牙釉质抗酸性的影响。
4) Sodium hydrogen carbonate
碳酸氢钠
1.
Determination of sodium carbonate and sodium hydrogen carbonate in solid mixed alkali by inductively coupled plasma atomic emission spectrometry with gaseous sample introduction
气态进样-电感耦合等离子体原子发射光谱法测定固体混合碱中的碳酸钠和碳酸氢钠
2.
The titration of the sodium hydrogen carbonate content in medicinal sodium bicarbonate tablet was compared with microburette under syringe control made on our own with conventional burette.
药用小苏打片中ＮａＨＣＯ３的微型滴定分析杨左海（咸宁医学院化学教研室湖北４３７１００关键词小苏打片碳酸氢钠微型滴定法常规滴定法中图分类号Ｏ６５５。
3.
An experimental method is successfully used to distinguish the sodium carbonate and sodium hydrogen carbonate solution by mercuric chloride,and its feasibility is demonstrated theoretically.
成功地设计了氯化汞鉴别碳酸钠和碳酸氢钠溶液的实验方法,并从理论上论证了HgCl2鉴别Na2CO3和NaHCO3溶液的可能性。
5) NaHCO 3
碳酸氢钠
1.
Determination and Calculation of Solubilities of CH 4 in Aqueous NaHCO 3 Solution at High Temperatures and High Pressures;
高温高压下甲烷在碳酸氢钠溶液中溶解度测定及模型计算
2.
The effects of NaHCO 3 on the heating and puffing of starchy materials treated with microwave irradiation on the texture of puffed products were studied.
研究了碳酸氢钠对淀粉物料的微波加热效果、膨化效果及产品状态的影响 结果表明 :添加碳酸氢钠不影响淀粉物料的介电特性及微波加热效果 ,含碳酸氢钠样品的温度变化情况与对照样的一致 ;与对照样相比 ,添加量为 0 1 %时增加了物料的膨化动力 ,使产品膨化率略有提高 ,但对膨化速率及其膨化过程没有明显的影响 ,而添加量为 0 5 %时 ,其膨化过程和速率都比对照样差 ;碳酸氢钠含量在 0～ 0 2 %之间时 ,产品膨化率有一最佳值 ,而在 0 2 %以后 ,随其含量的增加 ,膨化率逐渐减小 ;碳酸氢钠的添加量在 0～ 0 2 %之间时 ,膨化产品内部结构疏松 ,在添加量为 0 5 %及更高时 ,产品则呈现类似于对照样的孔隙状态 ;产品的硬度随着碳酸氢钠含量的增加而增大 ,脆度逐渐减小 ;产品黄色渐深 ,碱味渐
3.
Objective To study the possibility and effects of transcatheter arterial embolization (TAE) through arterial infusion of NaHCO 3 and verapamil in Hepatocarcinoma by color dopple ultrasonography,and evaluate its improving effects on IL-2,IFN-α2b,ADM,and MMC.
目的 研究二维及彩色多普勒血流显像 (CDFI)在对肝癌患者进行肝动脉化疗及栓塞术 (TAE)中 ,经动脉灌注碳酸氢钠和维拉帕米的可行性和临床价值 ,评价对白细胞介素 -2 (IL -2 )、干扰素 (IFN -α 2b)和阿霉素(ADM )、丝裂霉素 (MMC)等药物的增效作用。
6) NaHCO3
碳酸氢钠
1.
Investigation of increasing efficacy of aterial infusion of NaHCO3 to solid malignant tumors in interventional chemotherapy;
经动脉向恶性实体肿瘤组织灌注碳酸氢钠提高化疗药物疗效的初步观察
2.
As compared to the experimental data, the calculated solubility is in good agreement with the data as the concentration of either compound in the system is low, and the calculated solubility are lower than the data as the concentration of two compounds (Na2CrO4, NaHCO3) are high.
９％，碳酸氢钠浓度计算值比实验值低２２％，需用实验值修正。
3.
Objective To establish a method to determine the content of KC1 and NaHCO3 in Macrogol Electrolytes Powder.
目的 建立测定聚乙二醇电解质散中氯化钾和碳酸氢钠混合物含量的方法。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条